Anti-proliferative and ROS-inhibitory activities reveal the anticancer potential of Caulerpa species.

Abstract

Seaweeds are considered a promising functional food and safe for human consumption as they have significant health benefits. Five abundant tropical seaweeds, Caulerpa racemosa var. macrophysa, Caulerpa scalpelliformis, Grateloupia indica, Sargassum linearifolium, and Spatoglossum asperum rich in metabolites, phenolic, and flavonoid compounds, were analyzed for the anti-proliferative and ROS inhibitory activities including transcript expression of cancer-linked key genes and apoptosis. C. racemosa var. macrophysa showed the maximum effective activities with a lower dose of extract, about 130 ± 30 and 23 ± 1μgml-1 EC50 dose for HeLa and Huh-7, respectively, followed by C. scalpelliformis, showing EC50 dose about 200 ± 10 and 140 ± 30μgml-1, respectively. Similarly, about 56% and 54% ROS inhibition were determined with Caulerpa spp. for HeLa and Huh-7 cells, respectively. Results indicated that tropical green seaweed Caulerpa spp. (C. racemosa var. macrophysa and C. scalpelliformis) have substantial potential of ROS inhibition. Further, it was observed that different cancer-linked marker proteins encoding genes were deferentially expressed with seaweed extracts in different cell lines. Overall, it is concluded that Caulerpa spp. are rich in antioxidant and anti-proliferative activities. Caulerpa spp. have potential to be explored further for cancer preventive properties or functional food or nutraceuticals applications.